BofA Maintains Buy Rating on Tenet Healthcare (THC)

Tenet Healthcare Corporation (NYSE:THC) is one of the 10 Undervalued Counter Cyclical Stocks to Buy Now.

On June 9, 2026, BofA lowered the firm’s price target on Tenet Healthcare Corporation (NYSE:THC) to $210 from $230 and maintained a Buy rating on the shares. BofA said it was lowering price targets for several hospital names because of lower multiples tied to the generally weak utilization backdrop.

Last month, Barclays analyst Andrew Mok lowered the firm’s price target on Tenet Healthcare Corporation (NYSE:THC) to $238 from $257 and maintained an Overweight rating on the shares following the Q1 report. Mok said Tenet “exhibited its ability to flex the acute cost structure” despite volume headwinds. Morgan Stanley also lowered the firm’s price target on Tenet to $254 from $260 and maintained an Overweight rating, saying the company’s consistent execution was evident in Q1, where EBITDA beat by 3.5% despite industry headwinds.

BofA Maintains Buy Rating on Tenet Healthcare (THC)

Earlier, Tenet Healthcare Corporation (NYSE:THC) reported Q1 adjusted EPS of $4.82, compared with consensus of $4.17, and revenue of $5.37B, compared with consensus of $5.4B. CEO Saum Sutaria said the company delivered strong results in both the Ambulatory and Hospital segments, supported by disciplined operations and strong free cash flow. Sutaria also said Tenet continues to support physician partners as it executes on its high acuity strategy and grows organically and inorganically.

Tenet Healthcare Corporation (NYSE:THC) operates as a diversified healthcare services company in the United States.

While we acknowledge the risk and potential of THC as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and doing so within a shorter time frame. If you are looking for an AI stock that is more promising than THC and that has 10,000% upside potential, check out our report about the cheapest AI stock.

READ NEXT: 33 Stocks That Should Double in 3 Years and Cathie Wood 2026 Portfolio: 10 Best Stocks to Buy. 

Disclosure: None. Follow Insider Monkey on Google News.

1281292 - 11759070 - 1